WALTHAM, Mass. (Sept. 9, 2008) — Inc. Magazine named IntrinsiQ, LLC, to its list of the 5,000 fastest-growing companies in the country. IntrinsiQ, the expert source of oncology insight, was also named one of the top 75 companies in Boston, and the top 100 health companies nationwide.
IntrinsiQ is considered oncology’s leading source of real-time, real-world data for cancer treatment – and is relied on by more than 500 oncologists and 28 of the top 30 global pharmaceutical companies. Its analysis of 2 million drug administrations yearly helps everyone in the care spectrum identify the most effective treatments and emerging best practices.
Inc. Magazine noted that: “As chemotherapy treatments grow more complex, and as doctor reimbursement continues to decline, more oncologists are using software to calculate, measure, and track chemotherapy treatments.”
The company was founded in response to the avoidable medical errors that caused the 1994 death of Betsy Lehman, the Boston Globe health reporter who accidentally received four times her prescribed chemotherapy dose.
IntrinsiQ was named the 75th top company in the Boston-Cambridge-Quincy and New Hampshire area, and the 95th top health company nationwide. It ranked 2,064 among 5,000 booming companies for its impressive growth rate. This is the first year IntrinsiQ applied for the ranking.
“We are a trusted resource for doctors, and help them ensure patient safety and improve their efficiency,” said Ted Owens, COO at IntrinsiQ. “This information is essential, and is certainly the foundation for our growth.”
The Inc. 5000 is ranked according to percentage growth from 2004 through 2007. The 5,000 companies that made the list accounted a collective revenue totaling $185 billion and a median three-year growth of 147 percent.
Inc.’s profile of IntrinsiQ is at http://www.inc.com/inc5000/2008/company-profile.html?id=200820640.
IntrinsiQ, LLC is the leading provider of medical oncology workflow solutions and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s market leading software application, IntelliDose®, captures the treatment decisions and details from more than 500 oncologists, for more than 19,500 unique patients, and regarding more than 128,000 drug administrations. The IntrinsiQ database is unrivaled in accuracy, detail and timeliness of information about the medical oncology care process. This database is the foundation of products and services that uniquely address the business information needs of pharmaceutical product managers, market researchers and financial analysts. For more information, please visit www.intrinsiq.com.
Inc.com, the daily resource for entrepreneurs, delivers how-to guides, advice, tools, breaking news, and rich multi-media to help business owners and CEOs start, run, and grow their businesses. Inc.com offers dynamic marketing solutions to help advertisers effectively reach Inc.com's audience of business leaders. Visit http://www.inc.com.
Ted Owens
(781) 434-3331
ted.owens@intrinsiq.com
Lesley Cannata
(617) 969-9192
lcannata@corporateink.com